QSS
CLVS

Quantitative Systematic Strategies’s Clovis Oncology, Inc. CLVS Stock Holding History

Quantitative Systematic Strategies’s Portfolio CLVS Stock Details CLVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-11,567
Closed -$208K – 705
2018
Q4 		$208K Buy
+11,567
New +$236K 0.05% 515
2017
Q3 		– Sell
-3,466
Closed -$319K – 580
2017
Q2 		$319K Sell
3,466
-671
-16% -$41.1K 0.08% 316
2017
Q1 		$263K Sell
4,137
-930
-18% -$56.5K 0.07% 282
2016
Q4 		$223K Buy
+5,067
New +$178K 0.09% 268
2016
Q3 		– Sell
-49,852
Closed -$751K – 532
2016
Q2 		$751K Buy
+49,852
New +$729K 0.35% 136
2016
Q1 		– Sell
-29,721
Closed -$1.02M – 839
2015
Q4 		$1.02M Buy
+29,721
New +$1.92M 0.28% 32
2014
Q4 		– Sell
-11,070
Closed -$525K – 447
2014
Q3 		$525K Buy
+11,070
New +$462K 0.31% 136

Other funds holding CLVS

PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return